<![CDATA[지아이셀 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=39964>Wed, 22 Apr 2026 19:48:14 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[GIセルがオプティアム·バイオテクノロジーズと契約を締結]]>https://www.newswire.co.kr/newsRead.php?no=957760Tue, 13 Dec 2022 11:03:52 +0900<![CDATA[GI CELL Enters Agreement with Optieum Biotechnologies]]>https://www.newswire.co.kr/newsRead.php?no=957759Tue, 13 Dec 2022 10:52:01 +0900<![CDATA[GICELL Proves Excellent Anti-tumor Efficacy in Various Solid Tumor-bearing Animal Model]]>https://www.newswire.co.kr/newsRead.php?no=955738Wed, 16 Nov 2022 11:06:50 +0900<![CDATA[GICELL to Collaborate with HK inno.N on Research and Development for next-generation CAR-NK Therapy]]>https://www.newswire.co.kr/newsRead.php?no=950517Thu, 01 Sep 2022 14:19:24 +0900